Jeddah, Saudi Arabia – Sunday the 30th of November 2025 –, GSK, a focused biopharma company, with expertise in developing innovative speciality medicines and vaccines, and Haala Energy, the leading commercial and industrial solar installer in the Kingdom, have officially inaugurated a 632-kilowatt peak rooftop and ground mount solar project at GSK’s Jeddah plant with a ribbon-cutting ceremony. The event celebrated the successful completion of the project and highlighted the private sector’s role in supporting the Kingdom’s ambitious climate goals outlined in Vision 2030.
The Solar Photovoltaic system, installed across approximately 4,800 square meters, has a capacity of 632 kWp. It is expected to generate 1,130 MWh of clean energy annually, reducing the facility’s carbon footprint by 635 tons of CO₂e per year and covering approximately 28% of its electricity consumption. This project reflects GSK’s commitment to advancing its sustainability ambition while also contributing to national renewable energy goals.
The project has secured approvals from the Saudi Electricity Company (SEC) under the Regulatory Framework for Small-Scale Solar PV Systems, and GSK has recently signed a connection agreement with the SEC.
Farrukh Rehan, VP & General Manager, Saudi Arabia at GSK, stated:
“Partnership is the engine of progress. Together with Haala Energy, we’ve delivered a project that is good for the climate, good for industry, and good for the communities we serve.”
Tarek Fida, the Site Director at GSK, stated:
“We are pleased to announce the successful completion of our solar energy project and extend our appreciation to the entire team for their dedication and effort throughout this process. We would also like to acknowledge & appreciate our collaboration with Haala Energy, whose expertise and commitment were instrumental in delivering this project to high standards.
This accomplishment marks a significant advancement towards supporting the Saudi Green Initiative’s objective of achieving net-zero emissions by 2060 and is aligned with GSK’s own sustainability goals. By investing in renewable energy, we have reduced our carbon footprint and made a valuable contribution to a more sustainable and environmentally responsible future.”
Saif Bdeir, Managing Director of Haala Energy, added:
“We are proud to celebrate the successful completion of this landmark project with GSK. Over the past year, our teams have worked hand-in-hand to deliver a state-of-the-art solar PV system that sets a benchmark for industrial sustainability in Saudi Arabia.”
About GSK
GSK is a focused biopharma company with expertise in developing innovative speciality medicines and vaccines. GSK has a leading portfolio of vaccines, speciality and general medicines, with a purpose to unite science, technology, and talent to get ahead of disease together. GSK has been operating in Saudi Arabia for more than 65 years as the first multinational pharmaceutical company to establish a manufacturing facility in the Kingdom in the early 1990s.
About Haala Energy
Founded at KAUST in 2017, HAALA Energy has quickly established itself as a leader in rooftop solar installations across Saudi Arabia, building a diverse portfolio of hybrid and on-grid projects for industrial and commercial clients across the country. HAALA plans to deploy a further 30 MWp of rooftop projects by 2027 as it builds the largest portfolio of rooftop projects in the Kingdom.